Compendium of Cancer Genome Aberrations

CNS5:Volunteer Assignments and Opportunities: Difference between revisions

← Older edit
VisualWikitext
No edit summary
m due date
 
(43 intermediate revisions by 5 users not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 17: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
|
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
|
|
----
----
Line 42: Line 44:
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 50: Line 52:
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|Riley Lochner (trainee);
Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 61: Line 64:
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|Disease
|Meenakshi Mehrotra
|Jieying Wu
|
|11/18/2025
|
|01/15/2026
|PENDING
|PENDING
|
|
|LS
|LS
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
Line 75: Line 78:
|6/27/2023
|6/27/2023
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 105: Line 108:
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|Disease
|Disease
|Scott Smith
|5/3/2024
|
|
|PENDING - email reminder 9/4/2025
|
|
|
|LS
|
|
|
|
|
|
|
Line 116: Line 119:
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|Laveniya Satgunaseelan
|
|
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 135: Line 138:
|
|
|2021 template added
|2021 template added
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
Line 156: Line 170:
|
|
|
|
|2021 template added
|
|-
|-
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|Disease
|Disease
|Jeremy Pulvers
|Layla Zhu
|9/13/2022<br />
|<br />3/2/2026
|
|
|PENDING
|PENDING
Line 171: Line 185:
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|Disease
|Disease
|Wahab Khan
|2/8/2026
|
|
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|
|-
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|Disease
|Disease
|Wahab Khan
|15/04/2025
|
|
|
|COMPLETE
|
|2/8/2026 (Feb 8)
|
|
|LS
|LS
|
|
Line 215: Line 229:
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|Disease
|Disease
|Milana.Djonovic (trainee), Laveniya/Madina
|4/26/2026
|6/15/2026
|PENDING
|
|
|
|LS
|
|
|
|
|
|
|
|
Line 245: Line 259:
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
Line 314: Line 339:
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|Disease
|Laveniya Satgunaseelan
|9/11/2024
|
|
|
|COMPLETE
|
|8/7/2025
|
|LS
|
|LS
|
|Used for testing 9/2024 somatic template
|
|
|-
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
Line 355: Line 380:
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
Line 380: Line 416:
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|Disease
|
|Laveniya Satgunaseelan
|
|2/4/2026
|
|30/6/2026
|
|PENDING
|
|
|
|
Line 391: Line 427:
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
Line 400: Line 447:
|
|
|-
|-
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|Disease
|
|
Line 411: Line 458:
|
|
|-
|-
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|Disease
|
|
Line 465: Line 501:
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
Line 488: Line 535:
|
|
|-
|-
|CHAPTER 3 (CHOROID PLEXUS TUMOURS)
|
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
|
|
----
----
Line 541: Line 589:
|
|
|-
|-
|CHAPTER 4 (EMBRYONAL TUMOURS)
|
====CHAPTER 4 (EMBRYONAL TUMOURS)====
|
|
----
----
Line 563: Line 612:
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|9/20/21
|
|
Line 585: Line 635:
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Disease
|Hannah Wollenzien
|1/11/2026
|
|
|Pending
|
|
|
|MS
|
|
|
|
|
|
|
|-
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|Disease
|
|
Line 682: Line 743:
|
|
|-
|-
|CHAPTER 5 (PINEAL TUMOURS)
|
====CHAPTER 5 (PINEAL TUMOURS)====
|
|
----
----
Line 712: Line 774:
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
Line 726: Line 799:
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Disease
|Fang Fang (trainee)+Katie Schieffer (mentor)
|11/19/2025
|6/15/2026
|Pending
|
|
|
|LS
|
|
|
|
|
|
|
|
Line 757: Line 830:
|
|
|-
|-
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
|
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
|
|
----
----
Line 779: Line 853:
|[[CNS5:Schwannoma|Schwannoma]]
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|Disease
|
|
Line 799: Line 939:
|
|
|-
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|
|
====CHAPTER 7 (MENINGIOMA)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
----
|-
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|[[CNS5:Meningioma|Meningioma]]
|Disease
|Disease
|
|
Line 821: Line 971:
|
|
|-
|-
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|Disease
|
|
Line 843: Line 1,014:
|
|
|-
|-
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|Disease
|
|
Line 854: Line 1,025:
|
|
|-
|-
|CHAPTER 7 (MENINGIOMA)
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Meningioma|Meningioma]]
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|Disease
|
|
Line 885: Line 1,047:
|
|
|-
|-
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
----
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|
|Disease
|
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|Disease
|
|
Line 927: Line 1,113:
|
|
|-
|-
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|[[CNS5:Chordoma|Chordoma]]
|Disease
|Disease
|
|
Line 938: Line 1,124:
|
|
|-
|-
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
|
----
|-
|-
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|Disease
|
|
Line 960: Line 1,156:
|
|
|-
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|Disease
|
|
Line 971: Line 1,167:
|
|
|-
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|Disease
|
|
Line 993: Line 1,199:
|
|
|-
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|Disease
|
|
Line 1,004: Line 1,221:
|
|
|-
|-
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|Disease
|
|
Line 1,015: Line 1,265:
|
|
|-
|-
|[[CNS5:Chordoma|Chordoma]]
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Disease
|Jennie Thurston
|7/2/2023
|
|
|PENDING
|
|
|MS
|
|
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
Line 1,025: Line 1,283:
|
|
|
|
|-
|CHAPTER 9 (MELANOCYTIC TUMOURS)
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
----
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
----
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
----
Line 1,045: Line 1,363:
|
|
----
----
|-
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|Disease
|
|
Line 1,068: Line 1,385:
|
|
|-
|-
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
----
----
Line 1,088: Line 1,406:
----
----
|-
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|Disease
|
|
Line 1,099: Line 1,417:
|
|
|-
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|Disease
|
|
Line 1,110: Line 1,428:
|
|
|-
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|Disease
|
|
Line 1,121: Line 1,439:
|
|
|-
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|Disease
|
|
Line 1,132: Line 1,450:
|
|
|-
|-
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|Disease
|
|
Line 1,143: Line 1,461:
|
|
|-
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
!'''Disease'''
|Disease
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Jennie Thurston
|7/2/2023
|
|
|PENDING
----
|
|
|MS
----
|
|2021 template added
|-
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|Disease
|
|
Line 1,176: Line 1,504:
|
|
|-
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|Disease
|
|
Line 1,187: Line 1,515:
|
|
|-
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
----
|-
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|CHAPTER 11 (GERM CELL TUMOURS)
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|-
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
!'''Disease'''
|Disease
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|
!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|
!'''Notes'''
|-
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|CHAPTER 13 (METASTASES TO THE CNS)
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|
|
|
|
|
|
|
|
|-
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|Jennifer Laffin
|8/22/2023
|
|PENDING
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|}
|}
Retrieved from "https://content.ccga.io/index.php/CNS5:Volunteer_Assignments_and_Opportunities"